| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 7.03e-05 | 4 | 69 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 7.03e-05 | 4 | 69 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.75e-04 | 6 | 69 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 6.34e-04 | 11 | 69 | 2 | GO:0004983 | |
| Domain | NPY4_rcpt | 1.35e-05 | 2 | 69 | 2 | IPR001933 | |
| Domain | Ribosomal_L3 | 4.03e-05 | 3 | 69 | 2 | IPR000597 | |
| Domain | RIBOSOMAL_L3 | 4.03e-05 | 3 | 69 | 2 | PS00474 | |
| Domain | Ryanrecept_TM4-6 | 4.03e-05 | 3 | 69 | 2 | IPR009460 | |
| Domain | RyR | 4.03e-05 | 3 | 69 | 2 | PF02026 | |
| Domain | Ribosomal_L3 | 4.03e-05 | 3 | 69 | 2 | PF00297 | |
| Domain | Ryanodine_rcpt | 4.03e-05 | 3 | 69 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 4.03e-05 | 3 | 69 | 2 | PF06459 | |
| Domain | Ribosomal_L3_CS | 4.03e-05 | 3 | 69 | 2 | IPR019926 | |
| Domain | Ryan_recept | 4.03e-05 | 3 | 69 | 2 | IPR013333 | |
| Domain | RIH_assoc | 2.00e-04 | 6 | 69 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.00e-04 | 6 | 69 | 2 | IPR013662 | |
| Domain | RIH_dom | 2.00e-04 | 6 | 69 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.00e-04 | 6 | 69 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.00e-04 | 6 | 69 | 2 | IPR015925 | |
| Domain | - | 2.00e-04 | 6 | 69 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.00e-04 | 6 | 69 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 2.00e-04 | 6 | 69 | 2 | PF08709 | |
| Domain | NPY_rcpt | 4.76e-04 | 9 | 69 | 2 | IPR000611 | |
| Domain | MIR | 5.94e-04 | 10 | 69 | 2 | PS50919 | |
| Domain | MIR | 5.94e-04 | 10 | 69 | 2 | PF02815 | |
| Domain | MIR | 5.94e-04 | 10 | 69 | 2 | SM00472 | |
| Domain | MIR_motif | 5.94e-04 | 10 | 69 | 2 | IPR016093 | |
| Domain | Peptidase_M28 | 8.67e-04 | 12 | 69 | 2 | IPR007484 | |
| Domain | Peptidase_M28 | 8.67e-04 | 12 | 69 | 2 | PF04389 | |
| Domain | Transl_B-barrel | 4.45e-03 | 27 | 69 | 2 | IPR009000 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14550562 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 3.88e-06 | 2 | 69 | 2 | 21531043 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16678258 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8921388 | ||
| Pubmed | Expression of Muscle-Specific Ribosomal Protein L3-Like Impairs Myotube Growth. | 3.88e-06 | 2 | 69 | 2 | 26684695 | |
| Pubmed | RPL3L-containing ribosomes determine translation elongation dynamics required for cardiac function. | 3.88e-06 | 2 | 69 | 2 | 37080962 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14985349 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 36882085 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8898078 | ||
| Pubmed | 5.50e-06 | 650 | 69 | 9 | 38777146 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 9242641 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18403125 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 22948152 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 26575790 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.16e-05 | 3 | 69 | 2 | 10788707 | |
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 1.16e-05 | 3 | 69 | 2 | 15024040 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18434746 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 1.16e-05 | 3 | 69 | 2 | 29730765 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.16e-05 | 3 | 69 | 2 | 7621815 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.16e-05 | 3 | 69 | 2 | 9204703 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18643873 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 11159936 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7876312 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 21881589 | ||
| Pubmed | Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. | 1.16e-05 | 3 | 69 | 2 | 8643460 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.16e-05 | 3 | 69 | 2 | 10473538 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7959768 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.16e-05 | 3 | 69 | 2 | 12213830 | |
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.16e-05 | 3 | 69 | 2 | 4600883 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7635066 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 9384575 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 18206662 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 9607712 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 7592911 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 23482488 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 2.32e-05 | 4 | 69 | 2 | 23413940 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 33060591 | ||
| Pubmed | VPS18 recruits VPS41 to the human HOPS complex via a RING-RING interaction. | 3.86e-05 | 5 | 69 | 2 | 28931724 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 7493937 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 3.86e-05 | 5 | 69 | 2 | 19011160 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 23918386 | ||
| Pubmed | p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates. | 3.86e-05 | 5 | 69 | 2 | 28320958 | |
| Pubmed | Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. | 4.11e-05 | 96 | 69 | 4 | 34599178 | |
| Pubmed | ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1. | 5.79e-05 | 6 | 69 | 2 | 37040401 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 19549818 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 19009018 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 5.79e-05 | 6 | 69 | 2 | 26025922 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.79e-05 | 6 | 69 | 2 | 16844763 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 5.79e-05 | 6 | 69 | 2 | 14592808 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.79e-05 | 6 | 69 | 2 | 25966694 | |
| Pubmed | 7.33e-05 | 217 | 69 | 5 | 34048709 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 11860456 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 20962236 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.08e-04 | 8 | 69 | 2 | 19033399 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 1.62e-04 | 1005 | 69 | 9 | 19615732 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 26463206 | ||
| Pubmed | 1.93e-04 | 143 | 69 | 4 | 32560809 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 19095005 | ||
| Pubmed | 2.73e-04 | 638 | 69 | 7 | 31182584 | ||
| Pubmed | Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. | 3.48e-04 | 14 | 69 | 2 | 11099500 | |
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 1538749 | ||
| Pubmed | 5.77e-04 | 191 | 69 | 4 | 20195357 | ||
| Pubmed | 7.95e-04 | 21 | 69 | 2 | 30662561 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 8.26e-04 | 1257 | 69 | 9 | 36526897 | |
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 9.55e-04 | 23 | 69 | 2 | 14715245 | |
| Pubmed | 1.04e-03 | 24 | 69 | 2 | 15308636 | ||
| Pubmed | 1.30e-03 | 407 | 69 | 5 | 12693553 | ||
| Pubmed | Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. | 1.52e-03 | 29 | 69 | 2 | 12652657 | |
| Pubmed | 1.78e-03 | 120 | 69 | 3 | 27320910 | ||
| Pubmed | Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin. | 1.97e-03 | 33 | 69 | 2 | 30323974 | |
| Interaction | ERC2 interactions | 1.14e-05 | 42 | 67 | 4 | int:ERC2 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.90e-05 | 3 | 46 | 2 | 287 | |
| GeneFamily | L ribosomal proteins | 7.46e-03 | 51 | 46 | 2 | 729 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.22e-07 | 197 | 69 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.15e-06 | 154 | 69 | 5 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 183 | 69 | 5 | ad7421623e4c0c5ba02eec56e9bdae43ebb88d90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.44e-05 | 199 | 69 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| Drug | 2-hydroxycarbazole | 2.55e-05 | 3 | 67 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 2.55e-05 | 3 | 67 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.55e-05 | 3 | 67 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.55e-05 | 3 | 67 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 2.55e-05 | 3 | 67 | 2 | CID000127713 | |
| Drug | aminodantrolene | 2.55e-05 | 3 | 67 | 2 | CID009570289 | |
| Drug | Mdcp | 2.55e-05 | 3 | 67 | 2 | CID006439121 | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; HL60; HT_HG-U133A | 2.65e-05 | 199 | 67 | 6 | 2908_DN | |
| Drug | PCB74 | 5.10e-05 | 4 | 67 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 5.10e-05 | 4 | 67 | 2 | CID006444275 | |
| Drug | SC 38249 | 5.10e-05 | 4 | 67 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 5.10e-05 | 4 | 67 | 2 | CID000035682 | |
| Drug | ethosuximide | 6.75e-05 | 74 | 67 | 4 | CID000003291 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.52e-05 | 3 | 67 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.52e-05 | 3 | 67 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | basophil percentage of leukocytes | 2.32e-04 | 243 | 67 | 5 | EFO_0007992 | |
| Disease | N-acetyl-beta-alanine measurement | 5.97e-04 | 16 | 67 | 2 | EFO_0021430 | |
| Disease | Malignant neoplasm of breast | 6.96e-04 | 1074 | 67 | 9 | C0006142 | |
| Disease | X-11470 measurement | 8.47e-04 | 19 | 67 | 2 | EFO_0021241 | |
| Disease | colorectal cancer, hormone replacement therapy | 1.07e-03 | 88 | 67 | 3 | EFO_0003961, MONDO_0005575 | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 1.85e-03 | 28 | 67 | 2 | EFO_0600005 | |
| Disease | Strabismus | 1.98e-03 | 29 | 67 | 2 | HP_0000486 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRDHFRGKSMAPHYV | 471 | Q86VI1 | |
| AHMKNYIARFGHGSA | 336 | Q9UG63 | |
| HGVSGIFMKYDLSSL | 286 | Q96RQ1 | |
| KGGHNSTMCFHYRDK | 196 | Q9UPC5 | |
| SHTYLGADMEEFHGR | 56 | Q96SW2 | |
| HGLYSLHRMFDIVGT | 21 | O75618 | |
| HSGMGRYHGKFTFDT | 326 | P48448 | |
| HSGLIHMFSIGRSYE | 156 | Q8N4T0 | |
| MHHFGYLLLVSGLTT | 586 | A7MBM2 | |
| LGLGTAYIHGMKHAT | 96 | O60762 | |
| GPSHMSFYVRAHKGS | 796 | Q7Z2K6 | |
| RRHDLSLMSHGSQYG | 141 | Q7Z6R9 | |
| DSLYGSRHLAAKMAS | 211 | Q16769 | |
| LSLFFTGHRKMSGAD | 996 | P49796 | |
| VHRGYLDLMGASQHS | 31 | Q9BRQ5 | |
| GDKYEMRSHGPTHSL | 1851 | O75147 | |
| SMYGVDLHHAKDSEG | 281 | Q9H4G0 | |
| RVFHKGTYSLRAGHM | 246 | P50391 | |
| RGSKSYLSHMGLFLF | 546 | Q86W28 | |
| KDHGTAFTIMHYAGR | 896 | Q9Y6X6 | |
| LKMVDSFHRVSLHYG | 996 | O75145 | |
| LAERGIGYHHSAMSF | 1256 | Q8IY21 | |
| TMFLLKSDSYGGRHH | 666 | Q10570 | |
| HALGLGHSRYSQALM | 216 | Q99542 | |
| HMSFHAYIRKLTGGA | 161 | Q8TAT6 | |
| HTYQGSGMLHLKKAR | 71 | P48552 | |
| AGNMRYSHSTGKHLS | 546 | O95447 | |
| HSHLSYLSVRGGFNM | 111 | P05162 | |
| ILGSLYHGDHLSRAM | 586 | P78563 | |
| TKTRLMKYGGHGYSH | 301 | Q96BW5 | |
| RDILKDGAAYHHAGM | 576 | A2PYH4 | |
| GYRGMLDTHHKLCTF | 126 | P55010 | |
| FGHGMCKLLSGFYHT | 101 | P51677 | |
| HLGKGHYSFYSMDIR | 76 | P17213 | |
| GYSTAKHLARLGMHV | 56 | Q8N5I4 | |
| RLMTGDTYTAHAGAK | 386 | P00519 | |
| MTGADSHAKRHHGYK | 16 | P15516 | |
| YMTLTTALHLHRGGS | 1786 | Q9P225 | |
| GHAILLRHSYSGMYL | 116 | Q92736 | |
| GFLHHMAGLSSSKLS | 206 | Q9BY77 | |
| SKMSYESHHPESGGR | 331 | Q8N2Y8 | |
| EGSMFGHGLKHLFHS | 76 | O75069 | |
| LAMRGLYHTYHSLLK | 276 | Q86X40 | |
| VHLTAFLGYKAGMTH | 41 | P39023 | |
| VHLTAFLGYKAGMTH | 41 | Q92901 | |
| YLIHGGMDSTRHSLA | 151 | P48378 | |
| FTLRHHKYGRFMSVS | 71 | Q8WVE7 | |
| TMYLSHERGRKGSHH | 281 | Q9BVH7 | |
| FSLHGSVMRHSLLKG | 126 | Q8N3P4 | |
| SGHHRAPSYSGLSMV | 261 | Q9UBP0 | |
| GYRRHLAMHAASSGD | 141 | Q9UPG8 | |
| HDTFGTTYGRIHMQK | 256 | Q9H7B2 | |
| SMCEYFGHRGSKQLH | 271 | Q6P3X8 | |
| YGSSIASHGKDMVHK | 66 | O95070 | |
| FGYLGDRHSRKATMS | 101 | Q6ZMD2 | |
| GHAVLLRHSFSGMYL | 106 | Q15413 | |
| RLHLEGYHGTAGDSM | 4146 | P22105 | |
| HGRHFTYKSITGDMA | 391 | Q9UMX1 | |
| SATFTSFGEYKHHMR | 461 | Q8NCP5 | |
| FAYDLSAVVMHHGKG | 596 | Q70CQ1 | |
| RVFHKGTYSLRAGHM | 246 | P0DQD5 | |
| MTVHDKFLALGTHYG | 51 | P49754 | |
| GDMHSGHFVTYRRSP | 446 | Q70CQ3 | |
| MLHGTTTLAFKFRHG | 56 | P28074 | |
| SRRSGMYVHCKLHTG | 241 | Q2VY69 | |
| ILHYSGHGMDLDKAL | 341 | Q6ZT21 | |
| QRFYHKADGMLHISG | 2591 | Q9NR99 | |
| KRMELSFGIHHYAGK | 821 | Q8NEV4 | |
| HKLYESLGFRHMGAS | 256 | Q8N9F0 | |
| SLGFRHMGASDHYVL | 261 | Q8N9F0 |